AON
38
4
MRK
32
5
WY
37
7
KMB
30
2
PNC
48
4
UPS
56
3
GD
45
6
O
20
-8
NTRS
44
7
AMP
46
2
ROK
34
2
BK
60
2
FMC
30
7
ICE
46
4
LOW
42
2
WAT
66
6
NI
60
4
FCX
42
2
SE
61
-7
VRTX
39
-8
AON
38
4
MRK
32
5
WY
37
7
KMB
30
2
PNC
48
4
UPS
56
3
GD
45
6
O
20
-8
NTRS
44
7
AMP
46
2
ROK
34
2
BK
60
2
FMC
30
7
ICE
46
4
LOW
42
2
WAT
66
6
NI
60
4
FCX
42
2
SE
61
-7
VRTX
39
-8
Financhill
Back

Triumph Financial Vs. Summit Therapeutics Industry Stock Comparison

Sell
24

TFIN
Triumph Financial

Last Price:
$87.23
Seasonality Move:
2.72%
Sell
46

SMMT
Summit Therapeutics

Last Price:
$16.66
Seasonality Move:
7.78%
Sell
24
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $85.00. The Score for TFIN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $18.18. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $18.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.41 Sell
Relative Strength Index (14 RSI): 32.05 Sell
Chaikin Money Flow: 105930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.62 - 99.58) Sell
Bollinger Bands (100): (79.7 - 98.72) Sell

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 48.68 Sell
Chaikin Money Flow: 1356879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 18.74) Sell
Bollinger Bands (100): (15.6 - 22.64) Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.41 Sell
20-day SMA: 91.42 Sell
50-day SMA: 96.65 Sell
200-day SMA: 83.79 Buy
8-day EMA: 87.2 Sell
20-day EMA: 90.94 Sell
50-day EMA: 92.92 Sell
200-day EMA: 85.38 Sell

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.11 Buy
20-day SMA: 18.21 Sell
50-day SMA: 18.8 Sell
200-day SMA: 12.96 Buy
8-day EMA: 18.17 Buy
20-day EMA: 18.28 Sell
50-day EMA: 18.54 Sell
200-day EMA: 14.22 Buy

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $1.22 per share.

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):